US EditionPublished • loading... • Updated
Closing arguments set to begin in Twitter shareholder trial accusing Musk of driving down stock
Shareholders allege Musk misled investors about Twitter's bot accounts to justify backing out of his $44 billion acquisition bid, impacting stock value and investment trust.
- A class-action lawsuit was filed against Elon Musk by Twitter shareholders, accusing him of misleading investors as he attempted to back out of his $44 billion deal to buy Twitter in 2022.
- The trial focused on Musk's claims that Twitter had a much higher number of fake and spam accounts than the 5% it had disclosed.
- Twitter's former CFO Ned Segal testified that the company did not file false filings to the SEC misstating its spam numbers, which were closer to 1%.
Insights by Ground AI
21 Articles
21 Articles
Closing arguments begin in Twitter shareholder trial accusing Musk of driving down stock
Closing arguments kicked off Tuesday in a trial filed against Elon Musk by former Twitter shareholders. The investors say the world’s richest man engaged in a pattern of deceptive behavior that misled investors as he attempted to back out of…
A Judge Just Ruled Elon Musk’s Ketamine Use Is Fair Game in the Twitter Shareholder Lawsuit
A Delaware judge has ruled that Elon Musk’s ketamine use can be examined as part of the ongoing shareholder lawsuit over his $44 billion acquisition of Twitter. The decision, handed down by Chancellor Kathaleen McCormick of the Delaware Court of Chancery, opens a line of inquiry that Musk’s legal team fought hard to shut down. They lost. The case itself centers on whether Musk breached his fiduciary duties to Tesla shareholders by diverting comp…
Coverage Details
Total News Sources21
Leaning Left6Leaning Right4Center6Last UpdatedBias Distribution38% Left, 37% Center
Bias Distribution
- 38% of the sources lean Left, 37% of the sources are Center
38% Left
L 38%
C 37%
R 25%
Factuality
To view factuality data please Upgrade to Premium
